healthcare pr
biotech
pharma
medtech

At Russo Partners, healthcare PR isn't a job. It's our way of life.
Particularly with our unique focus on biotech, pharma, medtech, diagnostics and healthcare services. Since our founding as Noonan Russo more than 20 years ago, we have been on a first-name basis with the people you need to be talking to. Which means you should be talking to us. READ MORE.

March 5, 2010
SCRM Hires Russo Partners for Groundbreaking Ceremony PR

March 3, 2010
MedAssurant Selects Russo Partners to Implement National PR Program

October 7, 2009
Tony Russo to Chair Panel – Getting on the MAP: Messaging and Positioning Towards Negotiations – at AdvaMed 2009

March 12, 2010
Arena will launch lorcaserin with partner or alone

March 11, 2010
CDI Launching iPS Cells For Screening

March 10, 2010
Cempra Announces the Completion of Phase 1 Studies for CEM-101, a Next-Generation Macrolide
public relations
Our partners share their PR insight and conversations with the who's who in healthcare.

Supporting Business Development for a Unique Protein Drug Optimization Technology
Ambrx made a fundamental advance in protein biosynthesis that enabled scientists to modify existing protein drugs. Now the company needed to optimize its messaging and complement its reach through PR initiatives targeting prospective investors and partners.
READ MORE.

Enabling New Genome Sequencing Technology to Stand Out in a Crowd
When 454 Life Sciences began developing a next-generation genome sequencer, it was one of several firms working on technology that would reduce the time and cost of sequencing. The company wanted to stand out in a crowded field.
READ MORE.


© 2009 Russo Partners
 site design and programming by bfwinteractive